Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells

Biochemical and Biophysical Research Communications

Volumn 379, Issue 3, 2009, Pages 726-731

  Saito, Yoshimasa ^a   Friedman, Jeffrey M ^a   Chihara, Yoshitomo ^a   Egger, Gerda ^a   Chuang, Jody C ^a   Liang, Gangning ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cancer; DNA methylation; Epigenetic therapy; MicroRNA; Tumor suppressor

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; MICRORNA; MIR 126; PROTEIN EGFL7; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER TUMOR; CANCER CELL; CONTROLLED STUDY; DEACETYLATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; HUMAN; HUMAN CELL; INTRON; PRIORITY JOURNAL; PROSTATE TUMOR; UPREGULATION;

ANTINEOPLASTIC AGENTS; AZACITIDINE; CELL LINE, TUMOR; ENDOTHELIAL GROWTH FACTORS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICRORNAS; NEOPLASMS; PHENYLBUTYRATES; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 58549108465     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.12.098     Document Type: Article

References (22)

1. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., and Golub T.R. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
2. Esquela-Kerscher A., and Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6 (2006) 259-269
3. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6 (2006) 857-866
4. Tavazoie S.F., Alarcon C., Oskarsson T., Padua D., Wang Q., Bos P.D., Gerald W.L., and Massague J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451 (2008) 147-152
5. Zhang J., Du Y.Y., Lin Y.F., Chen Y.T., Yang L., Wang H.J., and Ma D. The cell growth suppressor, mir-126, targets IRS-1. Biochem. Biophys. Res. Commun. (2008)
6. Wang X., Tang S., Le S.Y., Lu R., Rader J.S., Meyers C., and Zheng Z.M. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 3 (2008) e2557
7. Shen W.F., Hu Y.L., Uttarwar L., Passegue E., and Largman C. MicroRNA-126 regulates HOXA9 by binding to the homeobox. Mol. Cell Biol. 28 (2008) 4609-4619
8. Jones P.A., and Baylin S.B. The epigenomics of cancer. Cell 128 (2007) 683-692
9. Saito Y., Liang G., Egger G., Friedman J.M., Chuang J.C., Coetzee G.A., and Jones P.A. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer cell 9 (2006) 435-443
10. Lujambio A., Ropero S., Ballestar E., Fraga M.F., Cerrato C., Setien F., Casado S., Suarez-Gauthier A., Sanchez-Cespedes M., Gitt A., Spiteri I., Das P.P., Caldas C., Miska E., and Esteller M. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67 (2007) 1424-1429
11. Brueckner B., Stresemann C., Kuner R., Mund C., Musch T., Meister M., Sultmann H., and Lyko F. The human let-7a-3 locus contains an epigenetically regulated MicroRNA gene with oncogenic function. Cancer Res. 67 (2007) 1419-1423
12. Saito Y., and Jones P.A. Epigenetic activation of tumor suppressor microRNAs in human cancer cells. Cell Cycle 5 (2006) 2220-2222
13. Rodriguez A., Griffiths-Jones S., Ashurst J.L., and Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 14 (2004) 1902-1910
14. Baskerville S., and Bartel D.P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11 (2005) 241-247
15. Kim Y.K., and Kim V.N. Processing of intronic microRNAs. Embo. J. 26 (2007) 775-783
16. Fitch M.J., Campagnolo L., Kuhnert F., and Stuhlmann H. Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells. Dev. Dyn. 230 (2004) 316-324
17. Parker L.H., Schmidt M., Jin S.W., Gray A.M., Beis D., Pham T., Frantz G., Palmieri S., Hillan K., Stainier D.Y., De Sauvage F.J., and Ye W. The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 428 (2004) 754-758
18. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., and Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93 (1996) 9821-9826
19. Yang N., Coukos G., and Zhang L. MicroRNA epigenetic alterations in human cancer: one step forward in diagnosis and treatment. Int. J. Cancer 122 (2008) 963-968
20. Yoo C.B., and Jones P.A. Epigenetic therapy of cancer: past, present and future. Nat. Rev. Drug Discov. 5 (2006) 37-50
21. Nguyen C.T., Weisenberger D.J., Velicescu M., Gonzales F.A., Lin J.C., Liang G., and Jones P.A. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res. 62 (2002) 6456-6461
22. Wozniak R.J., Klimecki W.T., Lau S.S., Feinstein Y., and Futscher B.W. 5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene 26 (2007) 77-90